In the third installment of our special series in partnership with bioM茅rieux, Luis welcomes back Dr. Sonali Kalathiya, infectious diseases pharmacist and medical advisor at bioM茅rieux, to explore how innovation is accelerating antimicrobial susceptibility testing (AST).
Together they dive into FAST AST—a phenotypic susceptibility test that delivers actionable results directly from positive blood cultures in hours instead of days. They discuss how this technology works, how it complements molecular testing, and how it’s transforming patient care, antimicrobial stewardship, and laboratory workflows.
From implementation and training to real-world clinical impact, this episode uncovers what it truly means to diagnose resistance at the speed of AST.
馃帶 Tune in to learn how faster results are helping clinicians act sooner, optimize therapy, and improve patient outcomes.
This episode is sponsored by bioM茅rieux, a global innovator in infectious disease diagnostics.
Resources
Questions? Feedback? Send those to letstalkmicro@outlook.com
Want to support the podcast? Here's how:
Venmo:
Buy me a Ko-fi:
